JP2022530471A5 - - Google Patents
Info
- Publication number
- JP2022530471A5 JP2022530471A5 JP2021563360A JP2021563360A JP2022530471A5 JP 2022530471 A5 JP2022530471 A5 JP 2022530471A5 JP 2021563360 A JP2021563360 A JP 2021563360A JP 2021563360 A JP2021563360 A JP 2021563360A JP 2022530471 A5 JP2022530471 A5 JP 2022530471A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- neuroprotective compound
- compound
- neurodegeneration
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962838216P | 2019-04-24 | 2019-04-24 | |
| US62/838,216 | 2019-04-24 | ||
| PCT/CA2020/050547 WO2020215164A1 (en) | 2019-04-24 | 2020-04-24 | Compositions and methods for use of cannabinoids for neuroprotection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022530471A JP2022530471A (ja) | 2022-06-29 |
| JP2022530471A5 true JP2022530471A5 (https=) | 2023-05-02 |
| JP7633179B2 JP7633179B2 (ja) | 2025-02-19 |
Family
ID=72940570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021563360A Active JP7633179B2 (ja) | 2019-04-24 | 2020-04-24 | 神経保護のためのカンナビノイドの組成物及び使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230043428A1 (https=) |
| EP (1) | EP3958856A4 (https=) |
| JP (1) | JP7633179B2 (https=) |
| KR (1) | KR20220080045A (https=) |
| CN (1) | CN114007603A (https=) |
| AU (1) | AU2020261515B2 (https=) |
| CA (1) | CA3134764A1 (https=) |
| IL (1) | IL287536B2 (https=) |
| MX (1) | MX2021012960A (https=) |
| SG (1) | SG11202111809XA (https=) |
| WO (1) | WO2020215164A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115006404A (zh) * | 2022-08-09 | 2022-09-06 | 昆药集团股份有限公司 | 一种具有视神经保护功效的药物组合物及其应用 |
| WO2024091653A1 (en) * | 2022-10-27 | 2024-05-02 | Kemin Industries, Inc. | Use of a spearmint extract for retina neurotrophism |
| WO2024148117A2 (en) * | 2023-01-04 | 2024-07-11 | Florascience Inc. | Methods of treating neurodegenerative diseases or conditions |
| WO2025090133A1 (en) * | 2023-10-23 | 2025-05-01 | Inmed Pharmaceuticals Inc. | Compositions and methods for use of cannabinol compounds in neuroprotection |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2471987B (en) * | 2008-06-04 | 2012-02-22 | Gw Pharma Ltd | Anti-tumoural effects of cannabinoid combinations |
| EP2640379A4 (en) * | 2010-11-18 | 2014-08-13 | Pier Pharmaceuticals | LOW DOSED CANNABINOIDARY MEDICINES |
| BR122021018502B1 (pt) * | 2014-10-21 | 2022-05-03 | United Cannabis Corp | Formulação de canabinoide líquida |
| MA41299A (fr) * | 2014-12-30 | 2017-11-07 | Axim Biotechnologies Inc | Solutions ophtalmiques pour le traitement du glaucome et de la conjonctivite |
| CN107405314A (zh) * | 2015-02-27 | 2017-11-28 | 埃布公司 | 包含纯化的大麻素与至少一种类黄酮、萜或矿物质的组合的组合物 |
| AU2016225026A1 (en) * | 2015-02-27 | 2017-09-07 | Canopy Growth Corporation | Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral |
| US20170266153A1 (en) * | 2015-02-27 | 2017-09-21 | Ebbu, LLC | Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes |
| US20160282371A1 (en) * | 2015-03-28 | 2016-09-29 | Quantalytical Labs Inc. | Solid Phase Extraction, Derivatization with Crown Ethers, and Mass Spectrometry, Methods, Reagents and Kits |
| IL248149B (en) * | 2016-09-29 | 2020-03-31 | Garti Nissim | Dilutable formulations of cannbinoids and processes for their preparation |
| CN109963595B (zh) * | 2016-10-11 | 2023-02-03 | Gbs全球生物制药公司 | 用于治疗神经退行性疾病的含有大麻素的复合混合物 |
| WO2018118197A1 (en) * | 2016-12-21 | 2018-06-28 | Richard Postrel | Healthier aging in domesticated animals |
| WO2018205022A1 (en) * | 2017-05-08 | 2018-11-15 | Inmed Pharmaceuticals Inc. | Ocular drug delivery formulation |
| WO2018205038A1 (en) * | 2017-05-12 | 2018-11-15 | Tetra Bio-Pharma Inc. | Compositions comprising cannabinoids and terpenes useful in the treatment of cancer and vascular ocular disorders via inhibition of hedgehog signalling |
| US20170348277A1 (en) * | 2017-08-02 | 2017-12-07 | Bryan Ray Ruiz | Cannabinoid formulation including a vasodilator and ocular delivery of the same |
-
2020
- 2020-04-24 KR KR1020217036628A patent/KR20220080045A/ko not_active Withdrawn
- 2020-04-24 EP EP20794650.0A patent/EP3958856A4/en active Pending
- 2020-04-24 IL IL287536A patent/IL287536B2/en unknown
- 2020-04-24 JP JP2021563360A patent/JP7633179B2/ja active Active
- 2020-04-24 CN CN202080046190.4A patent/CN114007603A/zh active Pending
- 2020-04-24 SG SG11202111809XA patent/SG11202111809XA/en unknown
- 2020-04-24 US US17/606,003 patent/US20230043428A1/en active Pending
- 2020-04-24 CA CA3134764A patent/CA3134764A1/en active Pending
- 2020-04-24 MX MX2021012960A patent/MX2021012960A/es unknown
- 2020-04-24 WO PCT/CA2020/050547 patent/WO2020215164A1/en not_active Ceased
- 2020-04-24 AU AU2020261515A patent/AU2020261515B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022530471A5 (https=) | ||
| TW401300B (en) | Antiallergic composition for ophthalmic or nasal use | |
| TWI773706B (zh) | 用於眼用活性藥物成分輸送的固體環糊精複合物之製備 | |
| TWI618539B (zh) | 無刺激性眼用聚乙烯吡咯啶酮-碘組成物 | |
| CN100453066C (zh) | 利用结膜下储存库的药物释放系统 | |
| AU2009329024A1 (en) | Curcuminoids and its metabolites for the application in ocular diseases | |
| SA516380321B1 (ar) | مستحضرات للعين لتوصيل الدواء إلى الجزء الخلفي من العين | |
| CN102340993A (zh) | 向眼部递送受体酪氨酸激酶抑制性(RTKi)化合物的药物组合物 | |
| JP7716996B2 (ja) | 薬剤を含む水性組成物のｐＨを安定化させるための方法 | |
| JP2018521117A (ja) | シクロスポリンａ／シクロデキストリンナノ粒子の形成 | |
| JP2021091697A (ja) | 水性点眼点鼻用組成物 | |
| López-Cano et al. | New trends towards glaucoma treatment: Topical osmoprotective microemulsions loaded with latanoprost | |
| CN101687042A (zh) | 用于递送作为受体酪氨酸激酶抑制剂(RTKi)的化合物至眼部的药物制剂 | |
| US12576126B2 (en) | Nanoemulsion ophthalmic composition comprising cyclosporine and menthol, and preparation method thereof | |
| JP2022547231A5 (https=) | ||
| FR3077984A1 (fr) | Composition multiusage de torasemide | |
| TW201705956A (zh) | 唑系抗真菌藥之對眼瞼皮膚的投與 | |
| JP2022540572A (ja) | 眼疾患を治療するための組成物および方法 | |
| CN110022856B (zh) | 用于降低眼压的眼用组合物 | |
| TWI801053B (zh) | 眼用組合物 | |
| TW202345853A (zh) | 無防腐劑的眼科藥物乳劑及其應用 | |
| RU2521337C1 (ru) | Фармацевтическая композиция для лечения заболеваний глаз, связанных с нарушением метаболизма в тканях глаза и воспалительным поражением тканей глаза | |
| JP4778262B2 (ja) | 角膜疾患治療剤 | |
| RU2504372C1 (ru) | Глазные капли | |
| Abbas et al. | Nanoparticles Loaded Thermoresponsive In Situ Gel for Ocular Antibiotic Delivery against Bacterial Keratitis. Polymers 2022; 14: 1135 |